Given that RUNX1 expression has previously been correlated with a positive prognosis in hormone positive non-triple-negative breast cancer (non-TNBC) and negative prognosis in triple-negative breast cancer (TNBC) (Fernández et al., 2023; Koboldt et al., 2012; Stender et al., 2010), we sought to investigate whether DDR1 and CBFβ expression levels exhibit similar correlations. Here, DDR1 is linked to triple-negative breast carcinoma.